Imran Mohammed Yunus Fazlani – Trademark Portfolio
Entity Type: 01
Imran Mohammed Yunus Fazlani holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include 9PM, AFNAN, and M MAISON OUD. The owner is based in Dubai.
Near Clock Tower
Flat No.-1101, Emaar No. 1 Tower
Dubai , AE
Showing of trademarks Trademarks
Trademark Classifications
Imran Mohammed Yunus Fazlani's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Imran Mohammed Yunus Fazlani have?
Imran Mohammed Yunus Fazlani has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending, 1 abandoned.
What trademark classes does Imran Mohammed Yunus Fazlani file in?
Imran Mohammed Yunus Fazlani files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Imran Mohammed Yunus Fazlani's most well-known trademarks?
Imran Mohammed Yunus Fazlani's registered trademark portfolio includes well-known marks such as 9PM, AFNAN, and M MAISON OUD. These are among 3 currently registered trademarks in the portfolio.
What is Imran Mohammed Yunus Fazlani's trademark registration success rate?
Imran Mohammed Yunus Fazlani has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 4 applications are pending review.